Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer
NCT00212082
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
doxorubicin, docetaxel
Sponsor
National University Hospital, Singapore